Mivacurium.
The muscle relaxant mivacurium was introduced in 1988 as a non-depolarizing drug with the pharmacokinetic profile of suxamethonium. Like suxamethonium, mivacurium is hydrolyzed by plasma cholinesterase; however, it has proved to be slower in onset and considerably longer in its duration of action. Inspite of this, in clinically used doses, it is somewhat shorter acting than alternative non-depolarizing drugs.